Industrially relevant cell lines include both direct production hosts for recombinant proteins, vaccines and viral vectors, and biomedical models that serve as references for host-cell engineering and comparative studies. These cell lines support the development and worldwide supply of recombinant therapeutics, viral vaccines and gene therapies.